MedTrace Logo

Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System

NCT00528320 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2013-11-27

No results posted yet for this study

Summary

This study provides a continued access registry for cardiac resynchronization therapy with defibrillation (CRT-D), which helps to resynchronize (coordinate) the rhythm of the heart by helping the left ventricle contract (pump blood) more uniformly, in patients with severe heart failure (New York Heart Association \[NYHA\] Class III or IV).

Quality of life, adverse events and device success will be analyzed and reported.

Conditions

  • Congestive Heart Failure (CHF)

Interventions

DEVICE

Ovatio CRT

Sponsors & Collaborators

  • ELA Medical, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00528320 on ClinicalTrials.gov